{"id":235108,"date":"2026-04-24T07:38:00","date_gmt":"2026-04-24T11:38:00","guid":{"rendered":"https:\/\/news-you-need.com\/index.php\/2026\/04\/24\/b-cell-maturation-antigen-bcma-targeted-therapies-market\/"},"modified":"2026-04-24T09:35:09","modified_gmt":"2026-04-24T13:35:09","slug":"b-cell-maturation-antigen-bcma-targeted-therapies-market","status":"publish","type":"post","link":"https:\/\/news-you-need.com\/index.php\/2026\/04\/24\/b-cell-maturation-antigen-bcma-targeted-therapies-market\/","title":{"rendered":"B-Cell Maturation Antigen (BCMA) Targeted Therapies Market"},"content":{"rendered":"<p><a href=\"https:\/\/www.openpr.com\/news\/4487379\/b-cell-maturation-antigen-bcma-targeted-therapies-market\">B-Cell Maturation Antigen (BCMA) Targeted Therapies Market<\/a><\/p>\n<p><a href=\"https:\/\/www.openpr.com\/news\/4487379\/b-cell-maturation-antigen-bcma-targeted-therapies-market\">https:\/\/www.openpr.com\/news\/4487379\/b-cell-maturation-antigen-bcma-targeted-therapies-market<\/a><\/p>\n<p>Publish Date: <a href=\"publish_date]\">2026-04-24 07:38:00<\/a><\/p>\n<p>Source Domain: <a href=\"www.openpr.com\">www.openpr.com<\/a><\/p>\n<p>        According to Precedence Research, the global B-cell maturation antigen (BCMA) targeted therapies market size was valued at USD 5.60 billion in 2025 and is projected to surpass USD 29.81 billion by 2035, growing at a robust CAGR of 18.20% from 2026 to 2035. The surge is fueled by the rising prevalence of multiple myeloma, rapid adoption of next-generation immunotherapies such as CAR-T cells and bispecific antibodies, and strong clinical success in relapsed and refractory patients.<\/p>\n<p>As the oncology landscape shifts toward precision medicine, BCMA-targeted therapies are emerging as a cornerstone treatment approach, offering improved survival rates and durable responses for patients with limited options.<\/p>\n<p>Where Data Meets Strategic Clarity \ud83d\udce5 View Sample Pages of the Complete Report \ud83d\udc49 <span class=\"intext-a opr-li click-to-go-x\" style=\"color:#ed7000; cursor:pointer;\" data-url=\"https:\/\/opr.li\/com\/1f2f6424d0d9f927b89c63b0210fa17b\/\">https:\/\/www.precedenceresearch.com\/sample\/8328<\/span><\/p>\n<p>B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Forecasts<\/p>\n<p>\ud83d\udd39 Market size in 2025: USD 5.60 Billion<br \/>\n\ud83d\udd39 Market size in 2026: USD 6.62 Billion<br \/>\n\ud83d\udd39 Market size by 2035: USD 29.81 Billion<br \/>\n\ud83d\udd39 CAGR: 18.20% (2026-2035)<br \/>\n\ud83d\udd39 Forecast period: 2026-2035<br \/>\n\ud83d\udd39 Base year: 2025<\/p>\n<p>Why Are BCMA Therapies Gaining Momentum?<\/p>\n<p>BCMA-targeted therapies have rapidly transitioned from experimental treatments to mainstream oncology solutions. Multiple myeloma remains largely incurable, and conventional therapies often fail to deliver long-term remission. This has intensified the demand for targeted immunotherapies.<\/p>\n<p>Innovative approaches such as CAR-T therapies, antibody-drug conjugates (ADCs), and bispecific antibodies are revolutionizing treatment outcomes. Additionally, favorable regulatory frameworks and increasing collaborations between biotech firms and research institutions are accelerating product development.<\/p>\n<p>\ud83d\udd17 What&#8217;s Fueling the Next Wave of Growth? \ud83d\udc49 <span class=\"intext-a opr-li click-to-go-x\" style=\"color:#ed7000; cursor:pointer;\" data-url=\"https:\/\/opr.li\/com\/39d996f6435fea5ab5c7b0767e4dfa94\/\">https:\/\/www.precedenceresearch.com\/b-cell-maturation-antigen-targeted-therapies-market<\/span><\/p>\n<p>How is Artificial Intelligence Revolutionizing BCMA&#8230;<\/p>\n<p><a href=\"https:\/\/www.openpr.com\/news\/4487379\/b-cell-maturation-antigen-bcma-targeted-therapies-market\">Source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>B-Cell Maturation Antigen (BCMA) Targeted Therapies Market https:\/\/www.openpr.com\/news\/4487379\/b-cell-maturation-antigen-bcma-targeted-therapies-market Publish Date: 2026-04-24 07:38:00 Source Domain: www.openpr.com&#8230;<\/p>\n","protected":false},"author":1,"featured_media":235109,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/cdn.open-pr.com\/L\/4\/L424357765_g.jpg","fifu_image_alt":"","footnotes":""},"categories":[14],"tags":[20],"class_list":["post-235108","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artificial-intelligence","tag-artificial-intelligence"],"_links":{"self":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/235108"}],"collection":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=235108"}],"version-history":[{"count":1,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/235108\/revisions"}],"predecessor-version":[{"id":235110,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/235108\/revisions\/235110"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/235109"}],"wp:attachment":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=235108"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=235108"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=235108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}